Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soberlink is a U.S.-based digital health and medical device company that provides remote alcohol monitoring solutions for addiction treatment, family law, workplace compliance, and recovery support. Its core offering combines a professional-grade handheld breathalyzer with facial recognition, tamper detection, wireless connectivity, and a cloud-based reporting portal that delivers real-time test results to designated monitors. The company states that its system received FDA 510(k) clearance for medical use in 2016 and is used by treatment facilities and clinical programs across the United States. Soberlink is not a drug-development biotech or pharma company; rather, it is a commercial-stage healthcare technology business focused on alcohol monitoring, accountability, and documentation of sobriety. Its products are marketed as tools to improve trust, compliance, and outcomes in alcohol use disorder management and related monitoring settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soberlink Healthcare.